Resdiffra

Product

Heard on podcasts recently

Rezdiffra is the brand name for resmetirom, a thyroid hormone receptor beta agonist approved for adults with noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis.

Discussed inMarkets100%
CompareSet alert

Rank this week

—
Not in this week’s list

Share of the conversation

—

Reach this week

—

Tone this week

—

Not enough signal yet (fewer than 3 episodes scored).

Share of the conversation

Mentions of Resdiffra per 1,000 mentions of anything, 7-day rolling, all podcasts.

0.0‰0.02‰0.04‰0.06‰Aug 15Sep 6Sep 29Oct 21Nov 12
Show the data
DayShare (7-day)Mentions
Oct 230.02‰2
Nov 60.02‰2
Embed this

Paste this on your site to show Resdiffra's current trend:

<iframe src="https://podlume.ai/embed/e/resdiffra" width="360" height="220" style="border:0" loading="lazy" title="Resdiffra on PodLume Trends"></iframe>